DSM raises full-year outlook after strong second quarter

We are in the right segments to grow: DSM CEO

Dutch supplements maker DSM on Tuesday raised its outlook for 2016 as it reported an 18 percent rise in core earnings, helped by low material costs and tight cost controls, beating market forecasts.

The company, which reported earnings before interest, tax, depreciation and amortization of 328 million euros ($366.5 million) on sales of 1.9 billion euros, said it now expected EBITDA growth for the year "moving from high-single digit into the low to mid teens."

Analysts polled by Reuters had expected average EBITDA of 301 million euros on sales of 1.97 billion euros.

Related Tags